ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL HEART, LUNG, AND BLOOD INSTITUTE

Dysregulated NFkB Pathway Signaling In Myeloproliferative Neoplasms

Active
Institution
Washington University, MO
Principal investigator
Stephen Tracy Oh
Funding
$619K
Duration
2017–2027
Open portfolio

Moonbase score

Still being scored

Abstract

Project Summary/Abstract Myeloproliferative neoplasms (MPNs) are chronic blood disorders that that can cause severe symptoms and early death. New treatments have become available that help ameliorate symptoms, but they do not reliably slow or halt disease progression. We seek to better understand what drives disease development and progression in MPNs, so that we can develop better therapies for patients with these diseases. Our preliminary data indicates that the NFkB pathway is abnormally activated in MPNs. We hypothesize that NFkB pathway signaling contributes to the development of MPNs. Therefore, we have proposed a combination of mouse and human studies to determine how NFkB contributes to MPN pathogenesis, and to evaluate whether inhibition of NFkB pathway signaling may have potential therapeutic benefits for MPN patients.

LOADING MOONBASE SCORE

NATIONAL HEART, LUNG, AND BLOOD INSTITUTER01Hemostasis, Thrombosis, Blood Cells and Transfusion Study Section[HTBT]pathwayabnormallysignaling contributesneoplasmstreatments availabletherapeutic benefitsmpncontributes development

Questions for Washington University

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.